Flecainide Clinical Trials

3 actively recruiting trials across 1 location

▲ +1 trial since August 2026

Also known as: C01B C04

Pipeline

Phase 3: 1Phase 4: 2

Top Sponsors

University of Illinois at Chicago1
Universitaire Ziekenhuizen KU Leuven1
Oslo University Hospital1

Indications

Heart Disease3
Mitral Valve Prolapse1
Atrial Fibrillation (AF)1
Ventricular Arrhythmias and Cardiac Arrest1
Atrial Fibrillation1

Other2 trials

Effect and Safety of Flecainide and Metoprolol Versus Metoprolol Alone to Suppress Ventricular Arrhythmias in Arrhythmic Mitral Valve Prolapse

Phase 3

Flecainide Safety in Patients With Coronary Artery Disease and Atrial Fibrillation

Phase 4

Chicago, Illinois1 trial

Pharmacogenetic Study of Antiarrhythmic Drugs for Atrial Fibrillation

Jesse Brown VA Medical Center

Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.